Literature DB >> 32345050

A novel homozygous frameshift variant in the cellular retinaldehyde-binding protein 1 (RLBP1) gene causes retinitis punctata albescens.

Sónia Torres-Costa1, Carla Sofia Ferreira1, Ana Grangeia2, Renato Santos-Silva1,3, Elisete Brandão1, Sérgio Estrela-Silva1, Fernando Falcão-Reis1,3.   

Abstract

BACKGROUND: Retinitis punctata albescens is a form of retinitis pigmentosa characterized by white fleck-like deposits in the fundus, in most cases caused by pathogenic variants in RLBP1 gene. The purpose of this work is to report the phenotypic and genotypic data of a patient with retinitis punctata albescens carrying a deletion in the RLBP1 gene.
RESULTS: An 8-year-old Caucasian female has been complaining of nyctalopia for the last 2 years. No other ocular symptoms were present. No relevant past medical or familiar history was described. At clinical examination, the patient's best-corrected visual acuity was 20/20 in both eyes. Anterior segment evaluation and intraocular pressure were normal in both eyes. At fundoscopy, multiple punctate whitish-yellow fleck-like lesions were observed in the proximity of temporal superior and inferior vascular arcades. Scotopic electroretinogram demonstrated severely reduced rod response, without improvement or recovery of rod system function after prolonged dark adaptation. Blood DNA samples of this patient and from her parents were screened for causal variants in RLBP1, RDH5, and PRPH2.
CONCLUSION: A probable pathogenic frameshift variant was identified in homozygosity in the RLBP1 gene with an autosomal recessive transmission as another cause of retinitis punctata albescens. This DNA variant will aid ongoing functional studies and add to our understanding of the molecular pathology about RLBP1-associated retinopathies.

Entities:  

Keywords:  RLBP1 gene; flecked retina spectrum; retinitis pigmentosa; retinitis punctata albescens; rod-cone dystrophies

Year:  2020        PMID: 32345050     DOI: 10.1177/1120672120919064

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

1.  Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Adriano Carnevali; Chiara Del Noce; Davide Camposampiero; Marina Agrusta; Diego Ponzin; Marco Pellegrini; Sabrina Vaccaro; Massimo Nicolò; Vincenzo Scorcia; Carlo E Traverso; Giuseppe Giannaccare
Journal:  Ophthalmol Ther       Date:  2021-09-08

Review 2.  The Role of Vitamin A in Retinal Diseases.

Authors:  Jana Sajovic; Andrej Meglič; Damjan Glavač; Špela Markelj; Marko Hawlina; Ana Fakin
Journal:  Int J Mol Sci       Date:  2022-01-18       Impact factor: 5.923

3.  Novel variants in the RDH5 Gene in a Chinese Han family with fundus albipunctatus.

Authors:  Tianwei Qian; Qiaoyun Gong; Hangqi Shen; Caihua Li; Gao Wang; Xun Xu; Isabelle Schrauwen; Weijun Wang
Journal:  BMC Ophthalmol       Date:  2022-02-11       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.